CNTMF - Cansortium Inc.

Other OTC - Other OTC Delayed Price. Currency in USD
0.7400
-0.0700 (-8.64%)
At close: 3:52PM EDT
Stock chart is not supported by your current browser
Previous Close0.8100
Open0.8101
BidN/A x N/A
AskN/A x N/A
Day's Range0.6150 - 0.8101
52 Week Range0.6150 - 2.5000
Volume38,328
Avg. Volume39,933
Market Cap143.186M
Beta (3Y Monthly)N/A
PE Ratio (TTM)N/A
EPS (TTM)-0.0370
Earnings DateN/A
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target Est2.50
Trade prices are not sourced from all markets
  • Cansortium Announces Opening of its 15th Fluent™ Medical Marijuana Dispensary in Florida and Plans to Have 6 Additional Open by the End of the Year
    PR Newswire

    Cansortium Announces Opening of its 15th Fluent™ Medical Marijuana Dispensary in Florida and Plans to Have 6 Additional Open by the End of the Year

    MIAMI, Sept. 9, 2019 /PRNewswire/ - Cansortium Inc. ("Cansortium" or the "Company") (CSE:TIUM), a vertically-integrated, global provider of premium-quality medical cannabis operating under the Fluent™ brand, continues to expand its Florida retail footprint with the September 9th opening of a new Fluent dispensary in a prime location in Cape Coral, FL. Cansortium's Chief Executive Officer Jose Hidalgo noted, "As one of the first five licensed operators in Florida - the state with the fastest-growing medical marijuana patient population in the U.S. – we continue to capitalize on our first-mover position, executing our growth plan by steadily expanding our dispensary network to enhance access to our premium-quality Fluent cannabis products for medical marijuana patients across the state.

  • Benzinga

    Cansortium Attributes Lower Q2 Revenue To 'Unexpected Delays,' Halves 2019 Outlook

    Cansortium achieved positive consolidated EBITDA of $1.8 million versus pro-forma EBITDA of $5.8 million in the second quarter of 2018. Consolidated adjusted EBITDA for the quarter was a loss of $2.6 million, compared to adjusted pro-forma positive EBITDA of $100,000 in the same quarter of the previous year. For the first half of 2019, the company reported consolidated revenue of $11.6 million, up by 37% from pro-forma revenue of $8.5 million in the first half of 2018.

  • Cansortium Inc. Reports Second Quarter 2019 Financial Results; Revises Full Year 2019 Outlook; Expects to Achieve Profitability in Early 2020
    CNW Group

    Cansortium Inc. Reports Second Quarter 2019 Financial Results; Revises Full Year 2019 Outlook; Expects to Achieve Profitability in Early 2020

    Cansortium Inc. Reports Second Quarter 2019 Financial Results; Revises Full Year 2019 Outlook; Expects to Achieve Profitability in Early 2020

  • Cansortium, Inc. Second Quarter Financial Results and Conference Call Scheduled for August 29
    PR Newswire

    Cansortium, Inc. Second Quarter Financial Results and Conference Call Scheduled for August 29

    MIAMI , Aug. 22, 2019 /PRNewswire/ - Cansortium Inc. (CSE:TIUM) (OTCQB: CNTMF) ("Cansortium" or the "Company"), a leading Florida -based medical cannabis company operating under the ...

  • Cansortium Commences Trading on OTCQB Venture Market, Bringing Increased Visibility and Enhanced Liquidity
    PR Newswire

    Cansortium Commences Trading on OTCQB Venture Market, Bringing Increased Visibility and Enhanced Liquidity

    MIAMI, FL, Aug. 21, 2019 /PRNewswire/ - Cansortium Inc. ("Cansortium" or the "Company") (CSE:TIUM) (CNTMF), a vertically-integrated, global provider of premium-quality medical cannabis operating under the Fluent™ brand, announced today that it will begin trading today on the OTCQB Venture Market under the ticker "CNTMF".  This is an upgrade from the Company's previous classification on the Pink Open Market. Cansortium Chief Executive Officer Jose Hidalgo emphasized, "We are very pleased to begin trading on the OTCQB Venture Market less than five months after our initial public offering on the Canadian Securities Exchange, adding valuable visibility and additional liquidity for the benefit of our shareholders. U.S.-based investors can find current financial disclosure and Real-Time Level 2 quotes for the company at www.otcmarkets.com.

  • CNW Group

    Cansortium Announces Significant Expansion of its State-of-the-Art Tampa Cultivation Facility to Support Continued Growth in Florida Medical Marijuana Market

    MIAMI, FL , Aug. 19, 2019 /CNW/ - Cansortium Inc. ("Cansortium" or the "Company") (CSE:TIUM), a vertically-integrated, global provider of premium-quality medical cannabis operating under the Fluent™ brand, announced today that it has begun growing in Phase 2 at its state-of-the-art indoor medical marijuana cultivation facility in Tampa, Florida . Cansortium Chief Executive Officer Jose Hidalgo emphasized, "This Phase 2 expansion of our Tampa cultivation facility is another important step in support of our strategy to increase our revenue-generating capacity toward our goal of achieving operating profitability. "Expanding our Florida production capacity provides us with additional supply of high-quality cannabis to process into the wide variety of Fluent-branded medical marijuana products sold through our Florida dispensary network, currently comprising 15 dispensaries in key markets, which we expect to expand to more than 30 during 2020.

  • Cansortium Announces Opening of its Second Fluent™ Medical Marijuana Dispensary in Puerto Rico
    PR Newswire

    Cansortium Announces Opening of its Second Fluent™ Medical Marijuana Dispensary in Puerto Rico

    MIAMI, FL, Aug. 12, 2019 /PRNewswire/ - Cansortium Inc. ("Cansortium" or the "Company") (CSE:TIUM), a vertically-integrated, global provider of premium-quality medical cannabis operating under the Fluent™ brand, continues to expand its global retail footprint with the July 25 opening of a new Fluent dispensary in a prime location at the San Patricio Town Center in Calle Tabonuco, Guaynabo, Puerto Rico. Cansortium's Chief Executive Officer Jose Hidalgo noted, "The opening of our second Fluent dispensary in Puerto Rico is further evidence that we are executing our growth plan by steadily expanding our dispensary network to enhance access to our premium-quality Fluent cannabis products for medical marijuana patients in key markets.

  • Cansortium Announces Opening of its 14th Fluent™ Medical Marijuana Dispensary in Florida
    PR Newswire

    Cansortium Announces Opening of its 14th Fluent™ Medical Marijuana Dispensary in Florida

    MIAMI, FL, Aug. 7, 2019 /PRNewswire/ - Cansortium Inc. ("Cansortium" or the "Company") (CSE:TIUM), a vertically-integrated, global provider of premium-quality medical cannabis operating under the Fluent™ brand, continues to expand its Florida retail footprint with the August 1 opening of a new Fluent dispensary in a prime location in New Port Richey, FL. Cansortium's Chief Executive Officer Jose Hidalgo noted, "As one of the first five licensed operators in Florida - the state with the fastest-growing medical marijuana patient population in the U.S. – we continue to capitalize on our first-mover position, executing our growth plan by steadily expanding our dispensary network to enhance access to our premium-quality Fluent cannabis products for medical marijuana patients across the state.

  • Cansortium Announces Opening of its Newest Fluent™ Medical Marijuana Dispensary in Cutler Bay, Florida
    CNW Group

    Cansortium Announces Opening of its Newest Fluent™ Medical Marijuana Dispensary in Cutler Bay, Florida

    MIAMI , July 9, 2019 /CNW/ - Cansortium Inc. ("Cansortium" or the "Company") (CSE:TIUM), a vertically-integrated, global provider of premium-quality medical cannabis operating under the Fluent™ brand, continues to expand its Florida retail footprint with the July 5 th opening of a new Fluent dispensary in a prime location in Cutler Bay, FL. The new 2,654 square-foot store, located at 11245 SW 211 Street, is the Company's twelfth in Florida , with eighteen more locations expected to be opened or secured by the end of 2019. The Company's dispensaries carry a complete assortment of Fluent premium dried flower, and full spectrum concentrates and cartridges as well as creams, drops, capsules and suppositories.

  • Benzinga

    Cansortium Analyst Sees 'Dramatic Expansion' Potential In Canadian Cannabis Market

    Cansortium's focus is on the medical cannabis space in Florida, where it oversees 11 dispensaries and is considered a "large player" in the regulated cannabis market, Burleson said in the Friday initiation note.

  • Cansortium Comments on New Texas Law Enabling Access to Low-Level THC Cannabis Products for Texans Coping with Certain Chronic Medical Conditions
    PR Newswire

    Cansortium Comments on New Texas Law Enabling Access to Low-Level THC Cannabis Products for Texans Coping with Certain Chronic Medical Conditions

    MIAMI, June 18, 2019 /PRNewswire/ - Jose Hidalgo, Founder and CEO of Cansortium Inc. ("Cansortium" or the "Company") (CSE:TIUM), a vertically-integrated, global provider of premium-quality medical cannabis operating under the Fluent™ brand, issued the following statement in response to Texas Governor Greg Abbott's signing of HB 3703 which expands access to low-level THC (less than 0.5%) cannabis products to benefit Texas residents coping with certain chronic medical conditions. "The Cansortium team is excited to work with the State of Texas to provide cultivation, processing and home delivery operations in Texas in order to bring the benefits of our premium-grade, low-level THC, cannabis products to Texas residents who are coping with chronic medical conditions.

  • PR Newswire

    Cansortium Announces Opening of its Newest Fluent™ Medical Marijuana Dispensary in Melbourne, Florida

    MIAMI, June 10, 2019 /PRNewswire/ - Cansortium Inc. ("Cansortium" or the "Company") (CSE:TIUM), a vertically-integrated, global provider of premium-quality medical cannabis operating under the Fluent™ brand, continues to expand its Florida retail footprint with the opening of the newest Fluent dispensary in a prime location in Melbourne, FL. The new store will represent the Company's eleventh in Florida, with nineteen more locations expected to be opened or secured by the end of 2019. The new 1,700 square-foot Melbourne dispensary opening Monday, June 10, is located at 6340 N. Wickham Road.

  • Cansortium Inc. Reports First Quarter 2019 Financial Results; Reaffirms Full Year Outlook
    CNW Group

    Cansortium Inc. Reports First Quarter 2019 Financial Results; Reaffirms Full Year Outlook

    Cansortium Inc. Reports First Quarter 2019 Financial Results; Reaffirms Full Year Outlook

  • Newsfile

    Cansortium Inc. First Quarter Financial Results and Conference Call Scheduled for May 30

    Miami, Florida--(Newsfile Corp. - May 23, 2019) - Cansortium Inc. (CSE: TIUM) ("Cansortium" or the "Company"), a leading Florida-based medical cannabis company operating under the Fluent™ brand (formerly Knox Medical) and with a mission to deliver the highest standards of cannabis care from nursery to lab to shelf, will host a conference call on Thursday, May 30, 2019 at 5:00pm (ET) to review its first-quarter 2019 financial results, which will be released earlier that ...